Cancer Immunotherapy Drug Discovery Outsourcing Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032
CHAPTER 1. Industry Overview of Cancer Immunotherapy Drug Discovery Outsourcing Market
1.1. Definition and Scope
1.1.1. Definition of Cancer Immunotherapy Drug Discovery Outsourcing
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cancer Immunotherapy Drug Discovery Outsourcing Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cancer Immunotherapy Drug Discovery Outsourcing Market By Drug Type
1.2.3. Cancer Immunotherapy Drug Discovery Outsourcing Market By Cancer Type
1.2.4. Cancer Immunotherapy Drug Discovery Outsourcing Market By Service Type
1.2.5. Cancer Immunotherapy Drug Discovery Outsourcing Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.1.3. Driver 3
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.2.3. Restraint 3
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.3.3. Opportunity 3
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Cancer Immunotherapy Drug Discovery Outsourcing Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Cancer Immunotherapy Drug Discovery Outsourcing Market By Drug type
5.1. Introduction
5.2. Cancer Immunotherapy Drug Discovery Outsourcing Revenue By Drug type
5.2.1. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast, By Drug type, 2020-2032
5.2.2. Monoclonal Antibodies
5.2.2.1. Monoclonal Antibodies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Immunomodulators
5.2.3.1. Immunomodulators Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Oncolytic Viral Therapies and Cancer Vaccines
5.2.4.1. Oncolytic Viral Therapies and Cancer Vaccines Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Cancer Immunotherapy Drug Discovery Outsourcing Market By Cancer type
6.1. Introduction
6.2. Cancer Immunotherapy Drug Discovery Outsourcing Revenue By Cancer type
6.2.1. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast, By Cancer type, 2020-2032
6.2.2. Lung
6.2.2.1. Lung Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Breast
6.2.3.1. Breast Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Colorectal
6.2.4.1. Colorectal Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Melanoma
6.2.5.1. Melanoma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Prostate
6.2.6.1. Prostate Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Head and Neck
6.2.7.1. Head and Neck Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.8. Ovarian
6.2.8.1. Ovarian Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.9. Pancreatic
6.2.9.1. Pancreatic Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Cancer Immunotherapy Drug Discovery Outsourcing Market By Service type
7.1. Introduction
7.2. Cancer Immunotherapy Drug Discovery Outsourcing Revenue By Service type
7.2.1. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast, By Service type, 2020-2032
7.2.2. Target Identification and Validation
7.2.2.1. Target Identification and Validation Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Lead Screening and Characterization
7.2.3.1. Lead Screening and Characterization Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Cell-based Assays
7.2.4.1. Cell-based Assays Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Cancer Immunotherapy Drug Discovery Outsourcing Market By Country
8.1. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
8.2. U.S.
8.2.1. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
8.2.2. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
8.2.3. U.S. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
8.3. Canada
8.3.1. Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
8.3.2. Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
8.3.3. Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market By Country
9.1. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
9.2. U.K.
9.2.1. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
9.2.2. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
9.2.3. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
9.3. Germany
9.3.1. Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
9.3.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
9.3.3. Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
9.4. France
9.4.1. France Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
9.4.2. France Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
9.4.3. France Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
9.5. Spain
9.5.1. Spain Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
9.5.2. Spain Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
9.5.3. Spain Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
9.6.2. Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
9.6.3. Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market By Country
10.1. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
10.2. China
10.2.1. China Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
10.2.2. China Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
10.2.3. China Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
10.3. Japan
10.3.1. Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
10.3.2. Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
10.3.3. Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
10.4. India
10.4.1. India Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
10.4.2. India Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
10.4.3. India Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
10.5. Australia
10.5.1. Australia Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
10.5.2. Australia Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
10.5.3. Australia Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
10.6. South Korea
10.6.1. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
10.6.2. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
10.6.3. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
10.7.2. Rest of Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
10.7.3. Rest of Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
10.8. Asia-Pacific PEST Analysis
CHAPTER 11. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market By Country
11.1. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
11.2. Brazil
11.2.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
11.2.2. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
11.2.3. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
11.3. Mexico
11.3.1. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
11.3.2. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
11.3.3. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
11.4.2. Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
11.4.3. Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market By Country
12.1. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
12.2. GCC
12.2.1. GCC Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
12.2.2. GCC Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
12.2.3. GCC Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
12.3. South Africa
12.3.1. South Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
12.3.2. South Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
12.3.3. South Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Drug type, 2020-2032
12.4.2. Rest of Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Cancer type, 2020-2032
12.4.3. Rest of Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Billion) and Forecast By Service type, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Cancer Immunotherapy Drug Discovery Outsourcing Market
13.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Drug type Launches and Drug type Enhancements
13.2.3. Mergers And Acquisition In Global Cancer Immunotherapy Drug Discovery Outsourcing Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Horizon Discovery Group PLC
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2023
14.1.3.2. Horizon Discovery Group PLC Ingredients Ltd. 2023 Cancer Immunotherapy Drug Discovery Outsourcing Business Regional Distribution
14.1.4. Drug type /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Crown Bioscience, Inc.
14.3. Molecular Imaging, Inc.
14.4. Explicyte
14.5. STC Biologics, Inc
14.6. BPS Bioscience, Inc.
14.7. Personalis, Inc.
14.8. Celentyx Ltd.
14.9. HD Biosciences Co.
14.10. Promega Corporation
14.11. DiscoveRx Corporation
14.12. Genscript Biotech Corporation
14.13. ImmunXperts SA
Frequently Asked Questions
How big is the cancer immunotherapy drug discovery outsourcing market?
The cancer immunotherapy drug discovery outsourcing market size was valued at USD 1.26 billion in 2023.
What is the CAGR of the global cancer immunotherapy drug discovery outsourcing market from 2024 to 2032?
The CAGR of cancer immunotherapy drug discovery outsourcing is 10.9% during the analysis period of 2024 to 2032.
Which are the key players in the cancer immunotherapy drug discovery outsourcing market?
The key players operating in the global market are including Horizon Discovery Group PLC, Crown Bioscience, Inc., Molecular Imaging, Inc., Explicyte, STC Biologics, Inc, BPS Bioscience, Inc., Personalis, Inc., Celentyx Ltd., HD Biosciences Co., Promega Corporation, DiscoveRx Corporation, Genscript Biotech Corporation, and ImmunXperts SA
Which region dominated the global cancer immunotherapy drug discovery outsourcing market share?
North America held the dominating position in cancer immunotherapy drug discovery outsourcing industry during the analysis period of 2024 to 2032.
Which region registered fastest CAGR from 2024 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of cancer immunotherapy drug discovery outsourcing during the analysis period of 2024 to 2032.
What are the current trends and dynamics in the global cancer immunotherapy drug discovery outsourcing industry?
The current trends and dynamics in the cancer immunotherapy drug discovery outsourcing industry include increasing demand for personalized medicine and targeted therapies, rise in cancer prevalence globally, driving the need for innovative treatments, and cost-efficiency and time-saving benefits of outsourcing drug discovery processes.
Which drug type held the maximum share in 2023?
The monoclonal antibodies drug type held the maximum share of the cancer immunotherapy drug discovery outsourcing industry.?
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
